Literature DB >> 2226377

Pathways of human exposure to arsenic in a community surrounding a copper smelter.

L Polissar1, K Lowry-Coble, D A Kalman, J P Hughes, G van Belle, D S Covert, T M Burbacher, D Bolgiano, N K Mottet.   

Abstract

Several studies have found elevated levels of urinary arsenic among residents living near a copper smelter in Tacoma, Washington. To assess pathways of exposure to arsenic from the smelter, biological and environmental samples were collected longitudinally from 121 households up to 8 miles from the smelter. The concentration of inorganic and methylated arsenic compounds in spot urine samples was used as the primary measure of exposure to environmental arsenic. Urinary concentration of arsenic dropped off to a constant background level within one-half mile of the smelter in contrast to environmental concentrations, which decreased more steadily with increasing distance. Among all age-sex-specific groups in all areas, only children ages 0-6 living within one-half mile of the smelter had elevated levels of arsenic in urine. A separate analysis of data for these children suggests that hand-to-mouth activity was the primary source of exposure. Inhalation of ambient air and resuspension of contaminated soil were not important sources of exposure for children or adults.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226377     DOI: 10.1016/s0013-9351(05)80128-8

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  14 in total

1.  Biological monitoring of occupational exposure to inorganic arsenic.

Authors:  P Apostoli; D Bartoli; L Alessio; J P Buchet
Journal:  Occup Environ Med       Date:  1999-12       Impact factor: 4.402

2.  Lead, cadmium, arsenic and zinc in the ecosystem surrounding a lead smelter.

Authors:  W Pilgrim; R N Hughes
Journal:  Environ Monit Assess       Date:  1994-08       Impact factor: 2.513

3.  Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

Authors:  J P Buchet; J Staessen; H Roels; R Lauwerys; R Fagard
Journal:  Occup Environ Med       Date:  1996-05       Impact factor: 4.402

4.  Probabilistic prediction of exposures to arsenic contaminated residential soil.

Authors:  R C Lee; J C Kissel
Journal:  Environ Geochem Health       Date:  1995-12       Impact factor: 4.609

5.  Migration of contaminated soil and airborne particulates to indoor dust.

Authors:  David W Layton; Paloma I Beamer
Journal:  Environ Sci Technol       Date:  2009-11-01       Impact factor: 9.028

6.  Exposure to inorganic arsenic in soil increases urinary inorganic arsenic concentrations of residents living in old mining areas.

Authors:  Andrea L Hinwood; Malcolm R Sim; Damien Jolley; Nick de Klerk; Elisa B Bastone; Jim Gerostamoulos; Olaf H Drummer
Journal:  Environ Geochem Health       Date:  2004-03       Impact factor: 4.609

7.  Evaluation of exposure to arsenic in residential soil.

Authors:  Joyce S Tsuji; Maria D Van Kerkhove; Rhonda S Kaetzel; Carolyn G Scrafford; Pamela J Mink; Leila M Barraj; Eric A Crecelius; Michael Goodman
Journal:  Environ Health Perspect       Date:  2005-12       Impact factor: 9.031

8.  Human biomonitoring of arsenic and antimony in case of an elevated geogenic exposure.

Authors:  T W Gebel; R H Suchenwirth; C Bolten; H H Dunkelberg
Journal:  Environ Health Perspect       Date:  1998-01       Impact factor: 9.031

9.  Arsenic exposure within the Korean community (United States) based on dietary behavior and arsenic levels in hair, urine, air, and water.

Authors:  Bill Cleland; Ami Tsuchiya; David A Kalman; Russell Dills; Thomas M Burbacher; Jim W White; Elaine M Faustman; Koenraad Mariën
Journal:  Environ Health Perspect       Date:  2008-12-08       Impact factor: 9.031

10.  Lead, arsenic, and polycyclic aromatic hydrocarbons in soil and house dust in the communities surrounding the Sydney, Nova Scotia, tar ponds.

Authors:  Timothy W Lambert; Stephanie Lane
Journal:  Environ Health Perspect       Date:  2004-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.